Vera-Zambrano, A.; Lago-Docampo, M.; Gallego, N.; Franco-Gonzalez, J.F.; Morales-Cano, D.; Cruz-Utrilla, A.; Villegas-Esguevillas, M.; Fernández-Malavé, E.; Escribano-Subías, P.; Tenorio-Castaño, J.A.; Perez-Vizcaino, F.; Valverde, D.; González, T.; Cogolludo, A.; , . "Novel Loss of Function KCNA5 Variants in Pulmonary Arterial Hypertension.". Am J Respir Cell Mol Biol. (): . (2023). (PMID: 36917789).
Vera-Zambrano, A.; Baena-Nuevo, M.; Rinné, S.; Villegas-Esguevillas, M.; Barreira, B.; Telli, G.; de Benito-Bueno, A.; Blázquez, J.A.; Climent, B.; Pérez-Vizcaino, F.; Valenzuela, C.; Decher, N.; Gonzalez, T.; Cogolludo, A. "Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function.". Pharmacol Res. (): 106684. (2023). (PMID: 36740150).
Galán-Vidal, J.; Socuéllamos, P.G.; Baena-Nuevo, M.; Contreras, L.; González, T.; Pérez-Poyato, M.S.; Valenzuela, C.; González-Lamuño, D.; Gandarillas, A. "A novel loss-of-function mutation of the voltage-gated potassium channel Kv10.2 involved in epilepsy and autism.". Orphanet J Rare Dis. 17(1): 345. (2022). (PMID: 36068614).
Kiper, A.K.; Bedoya, M.; Stalke, S.; Marzian, S.; Ramírez, D.; de la Cruz, A.; Peraza, D.A.; Vera-Zambrano, A.; Márquez Montesinos, J.C.E.; Arévalo Ramos, B.A.; Rinné, S.; Gonzalez, T.; Valenzuela, C.; Gonzalez, W.; Decher, N. "Identification of a critical binding site for local anesthetics in the side pockets of Kv1 channels.". Br J Pharmacol. (): . (2021). (PMID: 33817777).
Naranjo, J.R.; Zhang, H.; Villar, D.; González, P.; Dopazo, X.M.; Morón-Oset, J.; Higueras, E.; Oliveros, J.C.; Arrabal, M.D.; Prieto, A.; Cercós, P.; González, T.; De la Cruz, A.; Casado-Vela, J.; Rábano, A.; Valenzuela, C.; Gutierrez-Rodriguez, M.; Li, J.Y.; Mellström, B. "Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease.". J. Clin. Invest.. (): . (2016). (PMID: 26752648).
Moreno, C.; Oliveras, A.; de la Cruz, A.; Bartolucci, C.; Muñoz, C.; Salar, E.; Gimeno, J.R.; Severi, S.; Comes, N.; Felipe, A.; González, T.; Lambiase, P.; Valenzuela, C. "A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome.". Cardiovasc. Res.. 107(4): 613-623. (2015). (PMID: 26168993).
David, M.; Macías, Á.; Moreno, C.; Prieto, Á.; Martínez-Mármol, R.; Vicente, R.; González, T.; Felipe, A.; Tamkun, M.M.; Valenzuela, C. "Protein kinase C (PKC) activity regulates functional effects of Kvβ1.3 subunit on KV1.5 channels: identification of a cardiac Kv1.5 channelosome.". J. Biol. Chem.. 287(25): 21416-21428. (2012). (PMID: 22547057).
Moral-Sanz, J.; Gonzalez, T.; Menendez, C.; David, M.; Moreno, L.; Macias, A.; Cortijo, J.; Valenzuela, C.; Perez-Vizcaino, F.; Cogolludo, A. "Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries.". Am. J. Physiol., Cell Physiol.. 301(1): C186-94. (2011). (PMID: 21490312).
Macías, A.; Moreno, C.; Moral-Sanz, J.; Cogolludo, A.; David, M.; Alemanni, M.; Pérez-Vizcaíno, F.; Zaza, A.; Valenzuela, C.; González, T. "Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.". J. Mol. Cell. Cardiol.. 49(6): 984-992. (2010). (PMID: 20858500).
Villalonga, N.; David, M.; Bielańska, J.; González, T.; Parra, D.; Soler, C.; Comes, N.; Valenzuela, C.; Felipe, A. "Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.". Biochem. Pharmacol.. 80(6): 858-866. (2010). (PMID: 20488163).
Decher, N.; Gonzalez, T.; Streit, A.K.; Sachse, F.B.; Renigunta, V.; Soom, M.; Heinemann, S.H.; Daut, J.; Sanguinetti, M.C. "Structural determinants of Kvbeta1.3-induced channel inactivation: a hairpin modulated by PIP2.". EMBO J.. 27(23): 3164-3174. (2008). (PMID: 18987637).
David, M.; Martínez-Mármol, R.; Gonzalez, T.; Felipe, A.; Valenzuela, C. "Differential regulation of Na(v)beta subunits during myogenesis.". Biochem. Biophys. Res. Commun.. 368(3): 761-766. (2008). (PMID: 18261980).
Arias, C.; Guizy, M.; David, M.; Marzian, S.; González, T.; Decher, N.; Valenzuela, C. "Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.". Anesthesiology. 107(4): 641-651. (2007). (PMID: 17893461).
Decher, N.; Kumar, P.; Gonzalez, T.; Pirard, B.; Sanguinetti, M.C. "Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation.". Mol. Pharmacol.. 70(4): 1204-1211. (2006). (PMID: 16835355).
Guizy, M.; Arias, C.; David, M.; González, T.; Valenzuela, C. "{Omega}-3 and {omega}-6 polyunsaturated fatty acids block HERG channels.". Am. J. Physiol., Cell Physiol.. 289(5): C1251-60. (2005). (PMID: 15987770).
Decher, N.; Kumar, P.; Gonzalez, T.; Renigunta, V.; Sanguinetti, M.C. "Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.". Mol. Pharmacol.. 68(4): 995-991005. (2005). (PMID: 16024663).
Caballero, R.; Gómez, R.; Moreno, I.; Nuñez, L.; González, T.; Arias, C.; Guizy, M.; Valenzuela, C.; Tamargo, J.; Delpón, E. "Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current.". Cardiovasc. Res.. 62(1): 86-95. (2004). (PMID: 15023555).
Arias, C.; González, T.; Moreno, I.; Caballero, R.; Delpón, E.; Tamargo, J.; Valenzuela, C. "Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels.". Cardiovasc. Res.. 57(3): 660-669. (2003). (PMID: 12618228).
Moreno, I.; Caballero, R.; González, T.; Arias, C.; Valenzuela, C.; Iriepa, I.; Gálvez, E.; Tamargo, J.; Delpón, E. "Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.". J. Pharmacol. Exp. Ther.. 304(2): 862-873. (2003). (PMID: 12538844).
Caballero, R.; Moreno, I.; González, T.; Arias, C.; Valenzuela, C.; Delpón, E.; Tamargo, J. "Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.". Circulation. 107(6): 889-895. (2003). (PMID: 12591761).
González, T.; Navarro-Polanco, R.; Arias, C.; Caballero, R.; Moreno, I.; Delpón, E.; Tamargo, J.; Tamkun, M.M.; Valenzuela, C. "Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels.". Mol. Pharmacol.. 62(6): 1456-1463. (2002). (PMID: 12435814).
González, T.; Arias, C.; Caballero, R.; Moreno, I.; Delpón, E.; Tamargo, J.; Valenzuela, C. "Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block.". Br. J. Pharmacol.. 137(8): 1269-1279. (2002). (PMID: 12466236).
Caballero, R.; Moreno, I.; González, T.; Valenzuela, C.; Tamargo, J.; Delpón, E. "Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5).". Cardiovasc. Res.. 56(1): 104-117. (2002). (PMID: 12237171).
Longobardo, M.; González, T.; Caballero, R.; Delpón, E.; Tamargo, J.; Valenzuela, C. "Bupivacaine effects on hKv1.5 channels are dependent on extracellular pH.". Br. J. Pharmacol.. 134(2): 359-369. (2001). (PMID: 11564654).
Caballero, R.; Delpón, E.; Valenzuela, C.; Longobardo, M.; González, T.; Tamargo, J. "Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.". Mol. Pharmacol.. 59(4): 825-836. (2001). (PMID: 11259627).
González, T.; Longobardo, M.; Caballero, R.; Delpón, E.; Tamargo, J.; Valenzuela, C. "Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.". J. Pharmacol. Exp. Ther.. 296(2): 573-583. (2001). (PMID: 11160646).
González, T.; Longobardo, M.; Caballero, R.; Delpón, E.; Sinisterra, J.V.; Tamargo, J.; Valenzuela, C. "Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kv1.5).". Br. J. Pharmacol.. 132(2): 385-392. (2001). (PMID: 11159686).
Longobardo, M.; González, T.; Navarro-Polanco, R.; Caballero, R.; Delpón, E.; Tamargo, J.; Snyders, D.J.; Tamkun, M.M.; Valenzuela, C. "Effects of a quaternary bupivacaine derivative on delayed rectifier K(+) currents.". Br. J. Pharmacol.. 130(2): 391-401. (2000). (PMID: 10807678).
Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401 Email:Info